Dawn Graham

This article is a stub. You can help by expanding it.

Biographical Information

Ms. Graham has served on the board of directors of Medivation "since April 2013. Ms. Graham is currently the Chair of our Nominating and Corporate Governance Committee and a member of our Compensation Committee. She retired in 2011 from Merck & Co., Inc. following a 23-year career there in commercial positions of increasing seniority, most recently President of Europe and Canada. In that role, Ms. Graham had full P&L responsibility for 30 European markets with annual sales of several billion dollars and an employee base of several thousand. Prior to those roles, she served as Vice President, Asia Pacific for Merck. In 2009, Ms. Graham was elected as One of the Most Powerful Women in Canada by the Canadian Women’s Executive Network. Ms. Graham received a B.A. in English and French Literature from Carleton University. She also served as a member of the Board of Rx&D, Canada’s research-based pharmaceutical companies association, from 2006 to 2009, and chaired that Board from 2008 to 2009. We recruited Ms. Graham to our board based on her extensive experience in commercialization of pharmaceutical products, including her substantial ex-U.S. commercialization expertise. "